Warren M. Zapol,Kenneth D. Bloch,Akito Nakagawa,Francine E. Lui,Revital Freedman
申请号：
US15111154
公开号：
US20160331783A1
申请日:
2015.01.13
申请国别(地区):
US
年份:
2016
代理人:
摘要：
This invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are allosteric effectors that reduce the oxygen-binding affinity of hemoglobin, which can enhance the efficacy of radiation therapy for cancer and which are useful for the treatment of ischemia and other conditions.
